Becton Dickinson and Company (BDX)vsMilestone Scientific (MLSS)
BDX
Becton Dickinson and Company
$177.85
+0.81%
HEALTHCARE · Cap: $48.05B
MLSS
Milestone Scientific
$0.44
+2.28%
HEALTHCARE · Cap: $41.61M
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 238553% more annual revenue ($22.48B vs $9.42M). BDX leads profitability with a 4.2% profit margin vs -44.0%. BDX earns a higher WallStSmart Score of 52/100 (C-).
BDX
Buy52
out of 100
Grade: C-
MLSS
Avoid21
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+11.1%
Fair Value
$203.14
Current Price
$177.85
$25.29 discount
Margin of Safety
+72.8%
Fair Value
$0.98
Current Price
$0.44
$0.54 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Revenue surging 22.3% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
ROE of 3.9% — below average capital efficiency
4.2% margin — thin
Earnings declined 31.4%
Trading at 11.1x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Price/Book. PEG of 1.11 suggests the stock is reasonably priced for its growth.
Bull Case : MLSS
The strongest argument for MLSS centers on Debt/Equity, Revenue Growth. Revenue growth of 22.3% demonstrates continued momentum.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Return on Equity, Profit Margin. Thin 4.2% margins leave little buffer for downturns.
Bear Case : MLSS
The primary concerns for MLSS are Price/Book, EPS Growth, Market Cap.
Key Dynamics to Monitor
BDX profiles as a value stock while MLSS is a growth play — different risk/reward profiles.
MLSS carries more volatility with a beta of 1.05 — expect wider price swings.
MLSS is growing revenue faster at 22.3% — sustainability is the question.
BDX generates stronger free cash flow (509M), providing more financial flexibility.
Bottom Line
BDX scores higher overall (52/100 vs 21/100). MLSS offers better value entry with a 72.8% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →Milestone Scientific
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company is headquartered in Livingston, New Jersey.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?